Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedSkin Solutions Dr. Suwelack AG is a German-based biotechnology company specializing in advanced tissue regeneration and professional skin care. The company is globally recognized for its proprietary Advanced CryoSafe Method, a unique manufacturing technology that preserves the native properties and biological activity of biomaterials such as collagen and elastin. Its flagship medical product, MatriDerm, is a three-dimensional acellular dermal matrix used extensively in the treatment of severe burns, chronic wounds, and reconstructive surgery. Beyond its medical division, the company operates a high-performance skincare division, providing both its own brands like 'reveel' and acting as a trusted CDMO partner for global aesthetics and dermatology companies. Headquartered in Billerbeck with a presence in Hamburg, the company combines scientific research with German manufacturing excellence to deliver innovative regenerative solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dr. Suwelack Skin and Healthcare.